# A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers

> **NCT05353010** · PHASE1 · UNKNOWN · sponsor: **HK inno.N Corporation** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** IN-A001(Tegoprazan)
- **DRUG:** IN-A001(Tegoprazan) + Tacrolimus

## Key facts

- **NCT ID:** NCT05353010
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05353010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05353010, "A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05353010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*